Acacium Group, a leading healthcare solutions provider, is headquartered in Great Britain and operates extensively across Europe and North America. Founded in 2003, the company has established itself in the healthcare staffing and clinical services industry, focusing on delivering innovative solutions that enhance patient care and operational efficiency. With a diverse portfolio that includes recruitment, clinical trial support, and workforce management, Acacium Group stands out for its commitment to quality and compliance. The company has achieved significant milestones, including strategic acquisitions that have expanded its service offerings and market reach. Recognised for its expertise and reliability, Acacium Group continues to strengthen its position as a trusted partner in the healthcare sector, driving advancements in clinical and operational excellence.
How does Acacium Group's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Mean score of companies in the Medical Device Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Acacium Group's score of 37 is higher than 60% of the industry. This can give you a sense of how well the company is doing compared to its peers.
In 2023, Acacium Group reported total carbon emissions of approximately 9,843,500 kg CO2e. This includes Scope 1 emissions of about 251,200 kg CO2e, Scope 2 emissions of approximately 246,700 kg CO2e, and significant Scope 3 emissions totalling around 9,345,600 kg CO2e. The latter category includes major contributions from business travel (about 1,195,800 kg CO2e), employee commuting (approximately 1,225,100 kg CO2e), and purchased goods and services (around 6,220,400 kg CO2e). In 2022, the Group's emissions were reported at approximately 7,987,120 kg CO2e, with Scope 1 emissions of about 195,210 kg CO2e, Scope 2 emissions of approximately 469,290 kg CO2e, and Scope 3 emissions totalling around 7,322,620 kg CO2e. This indicates a year-on-year increase in total emissions from 2022 to 2023. Acacium Group has set an ambitious target to achieve Net Zero emissions by 2040. The company has implemented a carbon management tool to measure and monitor its carbon footprint effectively. Their Responsible Business team, led by a dedicated Environmental Manager, oversees the carbon reduction plan, which aims for a year-on-year reduction of 5.3%. By 2030, they project a decrease in emissions to approximately 4,532,000 kg CO2e. The Group is also committed to the Science Based Targets initiative (SBTi), with a long-term target set for 2050. This commitment reflects their dedication to addressing climate change within the healthcare sector, where they operate.
Access structured emissions data, company-specific emission factors, and source documents
| 2021 | 2022 | 2023 | |
|---|---|---|---|
| Scope 1 | - | - | 000,000 |
| Scope 2 | - | - | 000,000 |
| Scope 3 | - | - | 0,000,000 |
Nearly all of their carbon footprint comes from suppliers and value chain emissions, representing nearly all emissions under the GHG Protocol, with "Purchased Goods and Services" being the largest emissions source at 67% of Scope 3 emissions.
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
Acacium Group has established climate goals through participation in recognized frameworks and target-setting initiatives. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.


Common questions about Acacium Group's sustainability data and climate commitments